ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling von Meng, Erhong, Mitra, Aparna, Tripathi, Kaushlendra, Finan, Michael A, Scalici, Jennifer, McClellan, Steve, Madeira da Silva, Luciana, Reed, Eddie, Shevde, Lalita A, Palle, Komaraiah, Rocconi, Rodney P

Volltext

Corrigendum to “Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.” [Neop... von Mani, Chinnadurai, Tripathi, Kaushlendra, Chaudhary, Sandeep, Somasagara, Ranganatha R., Rocconi, Rodney P., Crasto, Chiquito, Reedy, Mark, Athar, Mohammad, Palle, Komaraiah

Volltext

Validation of a venous thromboembolism risk assessment model in gynecologic oncology von Stroud, William, Whitworth, Jenny M, Miklic, Margaret, Schneider, Kellie E, Finan, Michael A, Scalici, Jennifer, Reed, Eddie, Bazzett-Matabele, Lisa, Straughn, J. Michael, Rocconi, Rodney P

Volltext

Second-line dovitinib (TKI258) in patients with FGFR2 -mutated or FGFR2 -non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage,... von Konecny, Gottfried E, Dr, Finkler, Neil, Prof, Garcia, Agustin A, MD, Lorusso, Domenica, MD, Lee, Paula S, MD, Rocconi, Rodney P, MD, Fong, Peter C, MBBS, Squires, Matt, PhD, Mishra, Kaushal, PhD, Upalawanna, Allison, PharmD, Wang, Yongyu, MD, Kristeleit, Rebecca, MD

Volltext

Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition von Mani, Chinnadurai, Tripathi, Kaushlendra, Chaudhary, Sandeep, Somasagara, Ranganatha R., Rocconi, Rodney P., Crasto, Chiquito, Reedy, Mark, Athar, Mohammad, Palle, Komaraiah

Volltext

The limited utility of currently available venous thromboembolism risk assessment tools in gynecologic oncology patients von Pannucci, Christopher J., MD, MS, Rocconi, Rodney P., MD

Volltext

A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer von CASE, Ashley S, ROCCONI, Rodney P, STRAUGHN, J. Michael, CONNER, Michael, NOVAK, Lea, WENQUAN WANG, HUH, Warner K

Volltext

Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance von Oh, Jonathan, Barve, Minal, Senzer, Neil, Aaron, Phylicia, Manning, Luisa, Wallraven, Gladice, Bognar, Ernest, Stanbery, Laura, Horvath, Staci, Manley, Meghan, Nemunaitis, John, Walter, Adam, Rocconi, Rodney P.

Volltext

Racial health disparities in ovarian cancer: not just black and white von Srivastava, Sanjeev K, Ahmad, Aamir, Miree, Orlandric, Patel, Girijesh Kumar, Singh, Seema, Rocconi, Rodney P, Singh, Ajay P

Volltext

Long-Term Follow-Up of Gemogenovatucel-T (Vigil) Survival and Molecular Signals of Immune Response in Recurrent Ovarian Cancer von Rocconi, Rodney P., Stanbery, Laura, Madeira da Silva, Luciana, Barrington, Robert A., Aaron, Phylicia, Manning, Luisa, Horvath, Staci, Wallraven, Gladice, Bognar, Ernest, Walter, Adam, Nemunaitis, John

Volltext

Society of Gynecologic Oncology Journal Club: Controversial conversations in gynecologic cancer – Navigating maintenance therapy for homologous recombinant proficient ovarian cance... von Goldsberry, Whitney N., Norquist, Barbara S., Rocconi, Rodney P., Modesitt, Susan C., Urban, Renata R.

Volltext

ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer von Rocconi, Rodney P., Stanbery, Laura, Tang, Min, Madeira da Silva, Luciana, Walter, Adam, Monk, Bradley J., Herzog, Thomas J., Coleman, Robert L., Manning, Luisa, Wallraven, Gladice, Horvath, Staci, Bognar, Ernest, Senzer, Neil, Brun, Scott, Nemunaitis, John

Volltext

MicroRNAs in gynecological cancers: Small molecules with big implications von Srivastava, Sanjeev K, Ahmad, Aamir, Zubair, Haseeb, Miree, Orlandric, Singh, Seema, Rocconi, Rodney P, Scalici, Jennifer, Singh, Ajay P

Volltext

Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer von Rocconi, Rodney P., Stanbery, Laura, Tang, Min, Madeira da Silva, Luciana, Walter, Adam, Monk, Bradley J., Herzog, Thomas J., Coleman, Robert L., Manning, Luisa, Wallraven, Gladice, Horvath, Staci, Bognar, Ernest, Senzer, Neil, Brun, Scott, Nemunaitis, John

Volltext

Immune checkpoint expression, microsatellite instability, and mutational burden: Identifying immune biomarker phenotypes in uterine cancer von Jones, Nathaniel L., Xiu, Joanne, Rocconi, Rodney P., Herzog, Thomas J., Winer, Ira S.

Volltext

Impact of Travel Time on Health Care Costs and Resource Use by Phase of Care for Older Patients With Cancer von Rocque, Gabrielle B, Williams, Courtney P, Miller, Harold D, Azuero, Andres, Wheeler, Stephanie B, Pisu, Maria, Hull, Olivia, Rocconi, Rodney P, Kenzik, Kelly M

Volltext

Corrigendum to “Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance” [Gynecol. Oncol. Rep. 34 (202... von Oh, Jonathan, Barve, Minal, Senzer, Neil, Aaron, Phylicia, Manning, Luisa, Wallraven, Gladice, Bognar, Ernest, Stanbery, Laura, Horvath, Staci, Manley, Meghan, Nemunaitis, John, Walter, Adam, Rocconi, Rodney P.

Volltext

Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial von Rocconi, Rodney P, Grosen, Elizabeth A, Ghamande, Sharad A, Chan, John K, Barve, Minal A, Oh, Jonathan, Tewari, Devansu, Morris, Peter C, Stevens, Erin E, Bottsford-Miller, Justin N, Tang, Min, Aaron, Phylicia, Stanbery, Laura, Horvath, Staci, Wallraven, Gladice, Bognar, Ernest, Manning, Luisa, Nemunaitis, John, Shanahan, David, Slomovitz, Brian M, Herzog, Thomas J, Monk, Bradley J, Coleman, Robert L

Volltext

CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival von Meng, Erhong, Long, Beverely, Sullivan, Paula, McClellan, Steve, Finan, Michael A., Reed, Eddie, Shevde, Lalita, Rocconi, Rodney P.

Volltext

A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer von Moore, Kathleen N, Herzog, Thomas J, Lewin, Sharyn, Giuntoli, Robert L, Armstrong, Deborah K, Rocconi, Rodney P, Spannuth, Whitney A, Gold, Michael A

Volltext